Artelon, a Marietta, GA-based medical device company, raised $20M in Series B funding.
The round was led by Vensana Capital.
The company intends to use the funds to accelerate commercial growth, clinical research, and expansion of its product line for surgical treatment of ankles and other joints.
Led by CEO Aaron Smith, Artelon is an orthopedic soft tissue reconstruction company. Dynamic Matrix® technology is a proprietary polymeric bio-textile for musculoskeletal soft tissue reconstruction. It is designed to mimic the natural mechanical and biological properties of healing ligament tissue. It has been proven in clinical studies to protect the surgical repair during early healing, quickly restore the mechanics of motion, and support development of regenerating tissue before dissolving over five to six years. Since its inception, its Dynamic Matrix has delivered enhanced biological and mechanical reconstruction with more than 60,000 implantations worldwide.
FinSMEs
25/05/2023